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Abstract The venom of Trimeresurus flavoviridis has three
disintegrins that act as platelet aggregation inhibitors by binding
to integrin KIIbL3 on platelets through its Arg-Gly-Asp
sequence. We isolated the cDNA encoding the flavostatin
precursor that is one of the disintegrins in T. flavoviridis venom.
The open reading frame consisted of four regions, a pre-peptide
region, a metalloprotease region, a spacer region and a
disintegrin region, indicating that the flavostatin precursor
belongs to the metalloprotease/disintegrin family. Surprisingly,
the deduced amino acid sequence of the metalloprotease region
was completely consistent with that of hemorrhagic metallopro-
tease HR2a, which indicated that this metalloprotease released
from the flavostatin precursor functions as a hemorrhagic factor.
These observations indicated that a disintegrin and a hemor-
rhagic metalloprotease were synthesized as a common precursor.
Thus, our results support the hypothesis that a disintegrin is
synthesized as a metalloprotease/disintegrin precursor and
matures by cleavage from the precursor molecule.
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1. Introduction
Viperidae snake venoms contain various components that
cause dysfunction of the blood coagulation system in their
prey. Disintegrins are such components and function as plate-
let aggregation inhibitors by binding to platelet integrin
KIIbL3 through the Arg-Gly-Asp (RGD) sequence [1]. Metal-
loproteases are also the major active principals of the lethal
toxin of viper venom. It is known that metalloproteases in
snake venoms possess speci¢c activities as hemorrhagic fac-
tors, ¢brolases and pro-thrombin and factor X activators [2].
Interestingly, all cDNAs encoding disintegrin precursors had
a metalloprotease region followed by a disintegrin region
through a short spacer region [3^7]. Neeper and Jacobson
reported the sequence of a cDNA encoding trigramin from
the venom of Trimeresurus gramineus (now renamed Trimere-
surus stejnegeri), but they did not translate a large nucleotide
sequence that is present upstream from the region encoding
the 72 residue mature trigramin [3]. Kini and Evans [4] and
Takeya et al. [5] translated all deduced amino acid sequences
and determined the domain structure of the trigramin precur-
sor. Analysis of the deduced amino acid sequences of cDNAs
encoding the precursors of rhodostomin from Calloselasma
rhodostoma venom [6] and trimucrin from T. mucrosquamatus
venom [7] also indicated that both precursors have metallo-
protease and disintegrin domains similarly to trigramin. These
observations suggested that both the metalloprotease and dis-
integrin mature by processing of a common precursor,
although these corresponding mature metalloproteases have
not been isolated.
The venom of Trimeresurus £avoviridis contains both dis-
integrins and hemorrhagic factors. Four hemorrhagic factors
and three disintegrins have been found in the venom of T.
£avoviridis and their amino acid sequences have been deter-
mined. The amino acid sequences of three disintegrins, £avor-
idin [8], tri£avin [9] and £avostatin [10], are highly homolo-
gous to one another and are completely identical from
residues 1 to 46. The four hemorrhagic factors found in the
venom of T. £avoviridis are HR1A [11], HR1B [11], HR2a [12]
and HR2b [12]. Both HR1A and HR1B that are high molec-
ular mass metalloproteases have disintegrin-like and Cys-rich
domains following the metalloprotease domain [13,14]. The
low molecular weight metalloproteases HR2a and HR2b
that are composed of only a metalloprotease domain have
high degrees of amino acid sequence identity [15,16].
In the present study, we isolated a cDNA encoding the full-
length precursor of £avostatin and analyzed its nucleotide
sequence. The deduced amino acid sequence of the open read-
ing frame (ORF) of the £avostatin precursor indicated that it
was composed of a pre-peptide domain, a metalloprotease
domain, a spacer domain and a disintegrin domain. Surpris-
ingly, the deduced amino acid sequence of the metalloprotease
domain was identical to that of hemorrhagic factor HR2a.
This is the ¢rst indication that a proportion of the low mo-
lecular weight hemorrhagic factors is expressed as a single
chain precursor protein also containing disintegrin which ma-
tures by cleavage between the metalloprotease and disintegrin
domains.
2. Materials and methods
2.1. Cloning of a HR2a/£avostatin precursor
Screening for cDNA encoding disintegrin was carried out by a
PCR-based method for high stringency screening of a DNA library
[17]. A Trimeresurus £avoviridis venom gland cDNA library [18] was
used as the template. Approximately 8.4U105 clones of Escherichia
coli in the T. £avoviridis venom gland cDNA library were divided into
64 wells (200 Wl/well, 1.3U104 clones/well) in a 96 well tissue culture
plate (Becton Dickinson). The pooled E. colis containing positive
clones as determined by PCR analysis were isolated and DNA sequen-
ces analysis was performed as described below.
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2.2. PCR analysis
Highly conserved parts of the nucleotide sequence in the disintegrin
region of three disintegrins, trigramin [3], rhodostomin [6] and trimu-
crin [7], were used as a sense primer (11^17S: AATCCGTGCTC-
GATGCTGC, amino acid positions 425^430 in Fig. 2) and an anti-
sense primer (45^51AS: TCACCCCTTGCTACTCCGGCA, amino
acid positions 459^465 in Fig. 2). Each PCR mixture (20 Wl ¢nal
volume) contained 2 pmol of each of the above primers, 1 U of
Taq polymerase (Promega), 200 WM of each dATP, dCTP, dTTP
and dGTP (Takara), 2 mM Mg2, 1UPCR bu¡er (Promega) and
0.4 Wg template. PCR was performed in a Zymoreactor (ATTO) for
30 cycles of 94‡C for 0.5 min to denature the template, 60‡C for 1 min
for primer annealing and 72‡C for 1 min for extension. After PCR,
samples were kept at 4‡C prior to gel analysis.
2.3. DNA sequence analysis
DNA sequencing was performed by the dideoxy chain termination
method using a Taq Dye Primer Cycle Sequencing kit, Taq Dye
Terminator Cycle Sequencing kit (Applied Biosystems) and a nucleo-
tide sequencer (model 373A, Applied Biosystems).
2.4. Oligonucleotide synthesis
Oligonucleotides for PCR and DNA sequencing were prepared with
a DNA synthesizer (model 381A, Applied Biosystems).
3. Results
3.1. Nucleotide sequence analysis
One cDNA clone encoding disintegrin was obtained from
cDNA library of T. £avoviridis venom gland by screening with
a PCR-based method. Fig. 1 shows the full nucleotide se-
quence and deduced amino acid sequence of this cDNA.
This cDNA was designated pro-£avostatin because the de-
duced amino acid sequence of its disintegrin region was iden-
tical to that of £avostatin that is isolated from the venom of
T. £avoviridis by Kawasaki et al. [10]. Pro-£avostatin had 81
bp of 5P-UTR, 1437 bp of ORF and 481 bp of 3P-UTR. A
putative poly-A signal (AATAAA) was detected at nucleotide
positions 1897^1902 of the 3P-UTR. The ORF consisted of a
54 bp signal region containing the initial ATG codon, a 516
bp pre-peptide region, a 606 bp metalloprotease region, a 54
bp spacer region and a 204 bp disintegrin region containing a
stop codon located at nucleotide positions 1435^1437. The
cDNA sequence of pro-£avostatin was homologous to those
Fig. 1. cDNA and deduced amino acid sequence of pro-£avostatin, which is the precursor of the hemorrhagic factor HR2a and disintegrin £a-
vostatin from T. £avoviridis venom. The nucleotide sequence is shown in the upper row, with the deduced amino acid sequence below. The ini-
tial ATG codon, putative signal peptide, hemorrhagic factor HR2a, £avostatin, Zn2-binding motif, RGD sequence and polyadenylation signal
are indicated by a waved underline, dotted underline, single underline, double underline, weak reversed letters, reversed letters and bold under-
line, respectively.
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of the disintegrin precursors pro-trigramin, pro-rhodostomin
and pro-trimucrin (data not shown).
3.2. Amino acid sequence analysis
The deduced amino acid sequence of the disintegrin region
encoded by pro-£avostatin was identical to that of £avostatin
[10]. Interestingly, the deduced amino acid sequence of the
metalloprotease region was consistent with the amino acid
sequence of the hemorrhagic factor HR2a which was analyzed
by Miyata et al. [15] (Fig. 1). The deduced amino acid se-
quence of the spacer region, 393-LRTDTVSTPVSGNE-
FLEA-410, between the metalloprotease and disintegrin re-
gions was homologous to those of the disintegrin precursors
pro-trigramin [3], pro-rhodostomin [6] and pro-trimucrin [7]
(Fig. 2). Furthermore, the pro-peptide region of the metal-
loprotease contained a predicted cysteine switch sequence
KMCGV [19] located at amino acid positions 165^169 (Fig. 2).
4. Discussion
In the present study, we determined the nucleotide sequence
of a cDNA encoding the £avostatin precursor. Its deduced
amino acid sequence was composed of a pre-peptide domain
of a metalloprotease domain, a spacer domain and a disinte-
grin domain of 190, 202, 18 and 69 residues, respectively.
Thus, it is clear that the £avostatin precursor belongs to the
metalloprotease/disintegrin family.
Interestingly, the amino acid sequence of the metallopro-
tease domain in the £avostatin precursor was consistent
with that of HR2a, a low molecular mass hemorrhagic factor
present in the venom of T. £avoviridis (Fig. 1). The precursors
of all three sequenced disintegrins, trigramin [3^5], rhodosto-
min [6] and trimucrin [7], also have both metalloprotease and
disintegrin domains. The only sequence analysis of a hemor-
rhagic factor, designated as rhodostoxin, isolated from the
venom of C. rhodostoma con¢rmed the deduced amino acid
sequence of the putative hemorrhagic protein encoded by the
pro-rhodostomin cDNA [20]. However, amino acid sequenc-
ing revealed that residue 291 is a threonine instead of a meth-
ionine (Fig. 2). Thus, the observations that pro-£avostatin
contains HR2a that functions as a hemorrhagic protein and
£avostatin that acts as a platelet aggregation inhibitor dis-
integrin represent the ¢rst indication that a portion of the
metalloprotease and disintegrin in snake venom is derived
by proteolysis from a common metalloprotease/disintegrin
precursor.
The metalloprotease/disintegrin precursor has three putative
scissor sites between each domain, i.e. the pre-peptide, metal-
loprotease, spacer and disintegrin domains. Shimokawa et al.
carried out an interesting experiment using Western blotting
to examine processing of recombinant pro-atrolysin E, which
is composed of a pre-peptide, a metalloprotease, a spacer and
a disintegrin-like domain that has a Met-Val-Asp sequence
instead of the RGD sequence [21]. Their results suggested
Fig. 2. Comparison of the deduced amino acid sequence of pro-£avostatin with those of other known disintegrin precursors. The single and
double underlines show proteins isolated as a metalloprotease and a disintegrin from crude venom, respectively. The dotted line indicates that a
highly similar protein was isolated from crude venom. Residues identical to those of pro-£avostatin are shaded. + shows the cysteine switch
site [19]. Weak reversed letters indicate the Zn2-binding site and consensus residues are noted above the sequence. Reversed letters represent
the Arg-Gly-Asp sequence. M, residue 291 of pro-rhodostomin, is a threonine in the amino acid sequence of rhodostoxin [20]. Pro-trigramin,
T. gramineus [3^5]; pro-trimucrin, T. mucrosquamatus [7] ; pro-rhodostomin, C. rhodostoma [6].
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that pro-atrolysin E is processed in order at the sites between
the pro-peptide and metalloprotease domains, spacer and dis-
integrin-like domains and metalloprotease and spacer do-
mains. Their experimental results did not allow the unequiv-
ocal determination of the ¢nal processing steps to yield
atrolysin E as found in venom lacking the spacer sequence,
but their study is the only one reported to date concerning
metalloprotease/disintegrin precursor processing. Pro-£avosta-
tin also belongs to the metalloprotease/disintegrin family and
possesses a metalloprotease domain that matures as a low
molecular weight hemorrhagic factor, HR2a, and a disintegrin
domain that becomes a platelet aggregation inhibitor, £avo-
statin. Accordingly, the HR2a/£avostatin precursor may ma-
ture by cleavage between metalloprotease and spacer domains
and spacer and disintegrin domains following proteolysis be-
tween the pro-peptide and metalloprotease domains (Fig. 3).
The high molecular weight hemorrhagic factors HR1A and
HR1B in the venom of T. £avoviridis underwent autoproteol-
ysis, in the absence of Ca2 at 37‡C for 3^12 h [14]. Under
these conditions, HR1A and HR1B each released a single
major fragment of 32 and 34 kDa composed of spacer, dis-
integrin-like and Cys-rich domains. Since these metallopro-
teases had already lost their pre-peptide domain, the ¢rst
processing site is potentially between the pro-peptide and met-
alloprotease domain because metalloprotease activity was ob-
served. Next, the site between the spacer and disintegrin do-
mains may be processed as well as pro-atrolysin E although
no fragment containing a metalloprotease and a spacer do-
main has yet been found in the snake venom.
With the exception of the spacer domain, functions of each
domain of the metalloprotease/disintegrin precursor have been
proposed. It is suggested that a cysteine switch in its pre-pep-
tide domain blocks the active site in the metalloprotease do-
main [19]. Its metalloprotease and disintegrin domains mainly
act as a hemorrhagic factor and platelet aggregation inhibitor,
respectively. However, no protein consisting of only a spacer
domain has yet been isolated and its function remains unclear.
Kini et al. reported that this spacer domain may not contrib-
ute signi¢cantly to the biological activity of precursor proteins
because a synthetic peptide based on this spacer domain
showed hardly any toxicity or biological activity [22].
In summary, we isolated and sequenced a cDNA encoding
a metalloprotease/disintegrin precursor. The deduced amino
acid sequence of the metalloprotease and disintegrin regions
of its cDNA corresponded with those of the hemorrhagic
factor HR2a [15] and the disintegrin £avostatin [9] from the
venom of T. £avoviridis, respectively. Thus, this is the ¢rst
study to clearly and directly demonstrate that the precursor
of the disintegrin £avostatin is synthesized with metallopro-
tease hemorrhagic factor HR2a through a spacer domain and
matures by proteolytic processing. The mature disintegrin and
metalloprotease from the same precursor might cooperate
synergistically in killing of a prey.
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Fig. 3. Schematic model of the predicted mechanism of activation
of the metalloprotease/disintegrin precursor. This is a modi¢cation
of Fig. 10 of Shimokawa et al. [21]. First, the pro-£avostatin pre-
cursor seems to be cleaved between the pro-peptide and metallopro-
tease domains to obtain metalloprotease activity. The next cleavage
site is probably between the spacer and disintegrin domain,
although conclusive evidence for this has not been obtained.
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